Impact of concomitant medications on the oncologic efficacy of systemic therapy in patients with advanced or metastatic urothelial carcinoma: a systematic review and meta-analysis

Impact of concomitant medications on the oncologic efficacy of systemic therapy in patients with advanced or metastatic urothelial carcinoma: a systematic review and meta-analysis

Abstract Background Immune checkpoint inhibitors (ICI) and chemotherapy, including antibody-drug conjugates, are widely used for the treatment of patients with advanced unresectable or metastatic urothelial carcinoma (UC). The majority of elderly patients receive concomitant medications to address v...

Full description

Saved in:
Bibliographic Details
Main Authors: Ichiro Tsuboi, Akihiro Matsukawa, Mehdi Kardoust Parizi, Marcin Miszczyk, Tamás Fazekas, Robert J Schulz, Ekaterina Laukhtina, Tatsushi Kawada, Satoshi Katayama, Takehiro Iwata, Kensuke Bekku, Pawel Rajwa, Koichiro Wada, Katharina Oberneder, Piotr Chlosta, Pierre I. Karakiewicz, Motoo Araki, Shahrokh F. Shariat
Format: Article
Language:English
Published: BMC 2025-04-01
Series:BMC Urology
Subjects:
Concomitant medications
Proton pump inhibitors
Antibiotics, steroids
Opioids
Histamine type-2 receptor antagonists
Immune checkpoint inhibitors
Online Access:https://doi.org/10.1186/s12894-025-01754-2
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s12894-025-01754-2

Similar Items